Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Autoimmune Disorders

  Free Subscription


2 Ann Neurol
2 BMC Neurol
1 Brain
3 Diabetes
2 Intern Med
5 J Autoimmun
1 J Immunol
1 J Nephrol
1 J Neurol
3 Kidney Int
8 Mult Scler
2 PLoS One
2 Proc Natl Acad Sci U S A
1 Thyroid

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Neurol

  1. LINDGREN U, Pullerits R, Lindberg C, Oldfors A, et al
    Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis.
    Ann Neurol. 2022;92:201-212.
    PubMed         Abstract available

  2. CACCIAGUERRA L, Carotenuto A, Pagani E, Mistri D, et al
    Ann Neurol. 2022 May 20. doi: 10.1002/ana.26419.
    PubMed         Abstract available

    BMC Neurol

  3. SMYTH P, Watson KE, Al Hamarneh YN, Tsuyuki RT, et al
    The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis - a randomized trial.
    BMC Neurol. 2022;22:275.
    PubMed         Abstract available

  4. WEI J, Zhang X, Yang F, Shi X, et al
    Gut microbiome changes in anti-N-methyl-D-aspartate receptor encephalitis patients.
    BMC Neurol. 2022;22:276.
    PubMed         Abstract available


  5. GOVERT F, Abrante L, Becktepe J, Balint B, et al
    Distinct movement disorders in contactin-associated-protein-like-2 antibody associated autoimmune encephalitis.
    Brain. 2022 Jul 25. pii: 6649472. doi: 10.1093.
    PubMed         Abstract available


  6. MALLONE R, Halliez C, Rui J, Herold KC, et al
    The beta-Cell in Type 1 Diabetes Pathogenesis: A Victim of Circumstances or an Instigator of Tragic Events?
    Diabetes. 2022;71:1603-1610.
    PubMed         Abstract available

  7. BAKER NL, Hammad SM, Hunt KJ, Semler A, et al
    Plasma ApoM levels and Progression to Kidney Dysfunction in Type 1 Diabetics.
    Diabetes. 2022 May 12. pii: 146945. doi: 10.2337/db21-0920.
    PubMed         Abstract available

  8. D'ADDIO F, Sabiu G, Usuelli V, Assi E, et al
    Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes.
    Diabetes. 2022 May 12. pii: 146944. doi: 10.2337/db22-0053.
    PubMed         Abstract available

    Intern Med

  9. IZUKA S, Natsumoto B, Shoda H, Fujio K, et al
    Jaccoud's Arthropathy in Systemic Lupus Erythematosus.
    Intern Med. 2022 Jul 22. doi: 10.2169/internalmedicine.0084.

  10. YAMADA S, Yamada K, Nishida H
    A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barre Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine.
    Intern Med. 2022 Jul 22. doi: 10.2169/internalmedicine.0319.

    J Autoimmun

  11. NATARAJA C, Flynn J, Dankers W, Northcott M, et al
    GILZ regulates type I interferon release and sequesters STAT1.
    J Autoimmun. 2022;131:102858.
    PubMed         Abstract available

  12. IYER VS, Boddul SV, Johnsson AK, Raposo B, et al
    Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2.
    J Autoimmun. 2022;131:102857.
    PubMed         Abstract available

  13. TAN Y, Yang S, Liu Q, Li Z, et al
    Pregnancy-related complications in systemic lupus erythematosus.
    J Autoimmun. 2022 Jul 21:102864. doi: 10.1016/j.jaut.2022.102864.
    PubMed         Abstract available

  14. LOU H, Ling GS, Cao X
    Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target.
    J Autoimmun. 2022 Jul 21:102861. doi: 10.1016/j.jaut.2022.102861.
    PubMed         Abstract available

  15. LI H, Boulougoura A, Endo Y, Tsokos GC, et al
    Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies.
    J Autoimmun. 2022 Jul 21:102870. doi: 10.1016/j.jaut.2022.102870.
    PubMed         Abstract available

    J Immunol

  16. MEIER LA, Faragher JL, Osinski V, Auger JL, et al
    CD47 Promotes Autoimmune Valvular Carditis by Impairing Macrophage Efferocytosis and Enhancing Cytokine Production.
    J Immunol. 2022;208:2643-2651.
    PubMed         Abstract available

    J Nephrol

  17. WU Q, Liang D, Song T, Ni X, et al
    Poor outcomes of proliferative glomerulonephritis with monoclonal IgG deposits in renal allografts: a retrospective multicenter study.
    J Nephrol. 2022 Jul 22. pii: 10.1007/s40620-022-01385.
    PubMed         Abstract available

    J Neurol

  18. CAPUANO R, Altieri M, Conte M, Bisecco A, et al
    Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod.
    J Neurol. 2022 Jul 26. pii: 10.1007/s00415-022-11296.
    PubMed         Abstract available

    Kidney Int

  19. MONTAGUD-MARRAHI E, Cuadrado-Payan E, Hermida E, Cacho J, et al
    Preemptive simultaneous pancreas kidney transplantation has survival benefit to patient.
    Kidney Int. 2022 May 26. pii: S0085-2538(22)00385.
    PubMed         Abstract available

  20. CHANG JC, Weiss PF, Xiao R, Atkinson MA, et al
    Use of renin angiotensin aldosterone system inhibitors in children with lupus and time to glucocorticoid discontinuation.
    Kidney Int. 2022;102:395-404.
    PubMed         Abstract available

  21. YU XJ, Wang SX
    Recognizing the true face of noninfectious cryoglobulinemic glomerulonephritis.
    Kidney Int. 2022;102:238-241.
    PubMed         Abstract available

    Mult Scler

  22. ZHONG M, van der Walt A, Monif M, Hodgkinson S, et al
    Prediction of relapse activity when switching to cladribine for multiple sclerosis.
    Mult Scler. 2022 Jul 27:13524585221111677. doi: 10.1177/13524585221111677.
    PubMed         Abstract available

  23. THEBAULT S, Bose G, Booth R, Freedman MS, et al
    Serum neurofilament light in MS: The first true blood-based biomarker?
    Mult Scler. 2022;28:1491-1497.
    PubMed         Abstract available

  24. XIANG B, Brier MR, Kanthamneni M, Wen J, et al
    Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS.
    Mult Scler. 2022;28:1515-1525.
    PubMed         Abstract available

  25. KLISTORNER S, Barnett MH, Graham SL, Wang C, et al
    The expansion and severity of chronic MS lesions follows a periventricular gradient.
    Mult Scler. 2022;28:1504-1514.
    PubMed         Abstract available

  26. STRIJBIS EM, Repovic P, Mostert J, Bowen JD, et al
    The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials.
    Mult Scler. 2022;28:1606-1619.
    PubMed         Abstract available

  27. ROGAWSKI DS, Nirschl JJ, McDonald J, Nie E, et al
    A rare neuromyelitis optica mimic: Primary CNS histiocytic sarcoma.
    Mult Scler. 2022;28:1651-1654.
    PubMed         Abstract available

    It is imperative to reconsider the concept of seronegative NMOSD.
    Mult Scler. 2022;28:1654-1655.

  29. MCGINLEY MP, Lapin B
    The value of patient-reported outcome measures for multiple sclerosis.
    Mult Scler. 2022;28:1489-1490.

    PLoS One

  30. BREW-SAM N, Desborough J, Parkinson A, Murugappan K, et al
    A user preference analysis of commercial breath ketone sensors to inform the development of portable breath ketone sensors for diabetes management in young people.
    PLoS One. 2022;17:e0269925.
    PubMed         Abstract available

  31. LOPEZ ORTEGA JM, Martinez PS, Acevedo-Leon D, Capell NE, et al
    Anti-TSH receptor antibodies (TRAb): Comparison of two third generation automated immunoassays broadly used in clinical laboratories and results interpretation.
    PLoS One. 2022;17:e0270890.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  32. DIEBOLD M, Galli E, Kopf A, Sanderson NSR, et al
    High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2022;119:e2205042119.
    PubMed         Abstract available

  33. GIRDHAR K, Huang Q, Chow IT, Vatanen T, et al
    A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes.
    Proc Natl Acad Sci U S A. 2022;119:e2120028119.
    PubMed         Abstract available


  34. LI L, Chen X, Li B, Liu D, et al
    Effect of Inactivated SARS-CoV-2 Vaccine on Thyroid Function and Autoimmunity within 28 days after the Second Dose.
    Thyroid. 2022 Jul 21. doi: 10.1089/thy.2022.0101.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.